Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5531904 | 0.95 | — | — | |
| Methane SCHEMBL2761950 | 0.92 | — | — | |
| SCHEMBL7159719 | 0.81 | — | — | |
| SCHEMBL7159813 | 0.77 | TSHR (0.37) | TSHRALDH1A1TDP1 | |
| SCHEMBL7164101 | 0.76 | TSHR (0.47) | TSHRALDH1A1 | |
| SCHEMBL6796953 | 0.72 | — | — | |
| SCHEMBL7691893 | 0.72 | — | — | |
| SCHEMBL27343568 | 0.71 | — | — | |
| SCHEMBL8932094 | 0.70 | — | — | |
| SCHEMBL28282352 | 0.70 | TSHR (0.52) | TSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1023 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387489-A1 | METHOD FOR PROVIDING A TOPICAL FORMULATION BASE | PEEP CLUB LTD (GB) | 2025-12-25 | — | — | US | claimed |
| US-20250332211-A1 | COMPOSITIONS FOR INHIBITING DEGRADATION OF HYALURONIC ACID AND METHODS OF USE THEREOF | EPIDARUS THERAPEUTICS LLC (US) | 2025-10-30 | — | — | US | claimed |
| US-12370231-B2 | Compositions for inhibiting degradation of hyaluronic acid and methods of use thereof | EPIDARUS THERAPEUTICS, LLC (US) | 2025-07-29 | — | — | US | claimed |
| WO-2024102364-A1 | SYSTEM AND METHOD FOR REMOTE SCREENING AND DIAGNOSIS OF CONTACT ALLERGIES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-05-16 | — | — | WO | claimed |
| US-20240148635-A1 | COSMETIC COMPOSITIONS COMPRISING POLYETHER POLYMERS | P2 SCIENCE, INC. | 2024-05-09 | — | — | US | claimed |
| US-11883453-B2 | Formulation based on medicinal plant, or part or extract thereof, use of the formulation and product including said formulation | PHYTOPLENUS BIOATIVOS S.A (BR) | 2024-01-30 | — | — | US | claimed |
| US-11872300-B2 | Cosmetic compositions comprising polyether polymers | P2 SCIENCE, INC. (US) | 2024-01-16 | — | — | US | claimed |
| US-20230363380-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-11-16 | — | — | US | claimed |
| WO-2023148531-A1 | SMALL MOLECULES FOR USE IN PREVENTING AND/OR TREATMENT OF NEURODEGENERATIVE DISEASES | TOXFINDER, LDA (PT) | 2023-08-10 | — | — | WO | claimed |
| WO-2023114999-A2 | MOISTURIZER COMPOSITIONS AND METHODS OF MAKING THE SAME | MOTAHARI ZAHRA (US) | 2023-06-22 | — | — | WO | claimed |
| EP-1776156-A1 | MICROPROJECTION APPARATUS AND SYSTEM WITH LOW INFECTION POTENTIAL | Alza Corporation, c/o Johnson & Johnson (US) | 2007-04-25 | — | — | EP | claimed |
| WO-2006044134-A2 | TEMPORARY WET STRENGTH AGENTS AND PRODUCTS MADE FROM SUCH AGENTS | LANXESS CORPORATION (US) | 2006-04-27 | — | — | WO | claimed |
| WO-2006044116-A2 | TEMPORARY WET STRENGTH AGENTS AND PRODUCTS MADE FROM SUCH AGENTS | LANXESS CORPORATION (US) | 2006-04-27 | — | — | WO | claimed |
| WO-2006020842-A1 | MICROPROJECTION APPARATUS AND SYSTEM WITH LOW INFECTION POTENTIAL | ALZA CORPORATION (US) | 2006-02-23 | — | — | WO | claimed |
| US-20060034902-A1 | Microprojection apparatus and system with low infection potential | ALZA CORPORATION | 2006-02-16 | — | — | US | claimed |
| US-20040247543-A1 | Sunscreen compositions | PLAYTEX PRODUCTS, INC. | 2004-12-09 | — | — | US | claimed |
| US-20020028754-A1 | Antimicrobial compositions | NOVOZYMES A/S (DK) | 2002-03-07 | — | — | US | claimed |
| WO-2002008377-A1 | ANTIMICROBIAL COMPOSITIONS | NOVOZYMES A/S (DK) | 2002-01-31 | — | — | WO | claimed |
| US-6231849-B1 | HUNTING | Schiller, George A. | 2001-05-15 | — | — | US | claimed |
| EP-0598412-A2 | Skinprotection composition | MEDICON GESELLSCHAFT FÜR UNTERNEHMENSBERATUNG IM BEREICH MEDIZIN UND GESUNDHEITSWESEN mbH (DE) | 1994-05-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148635-A1 | COSMETIC COMPOSITIONS COMPRISING POLYETHER POLYMERS | CUTA, LAGE3, POLR1C | TSHR 2071/4885ALDH1A1 364/4885TDP1 2078/4885 |
| US-11872300-B2 | Cosmetic compositions comprising polyether polymers | CUTA, LAGE3, POLR1C | TSHR 2071/4885ALDH1A1 364/4885TDP1 2078/4885 |
| US-20250387489-A1 | METHOD FOR PROVIDING A TOPICAL FORMULATION BASE | VEGFA, AQP3, DSG1 | TSHR 3688/4885ALDH1A1 4704/4885TDP1 740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.